Aurinia Pharmaceuticals Inc.    SEC # 1600620

        

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

Registrant
 SEC-Registered:  2/20/14   —   First EDGAR Filing:  2/28/14   –   Last Filing:  5/3/24 

Business Address      On:  5/3/24       [ Map ]		Mailing Address      On:  5/3/24       [ Map ]
#140, 14315 - 118 Avenue Edmonton, Alberta  T5L 4S6 Canada

Phone #		Organized In		Fiscal-Year End		IRS #		SEC CIK		SEC File #
+1 250-744-2487		Alberta, Canada		12/31/yy		98-1231763		0001600620		001-36421

Market: Symbol:  Nasdaq: AUPH

— Common Stock

In Major Indexes:	NASDAQ Composite — Russell 2000  &  Russell 3000

Industry Classification
GICS – Global Industry Classification Standard:        Sector      →    Sub-Industry   Health Care Biotechnology   ICB – Industry Classification Benchmark:               Industry    →       Subsector      Health Care Biotechnology   SIC:     Code      U.S. Industry      Through      Source      Filings-Review Office 2834 Pharmaceutical Preparations 2024 SEC Office of Life Sciences

        

Management
Director   In   MD   Greenleaf Peter 2021-2024   Balakrishnan Brinda 2021-2023   Billen Daniel 2021-2023   CA   Hagan Joseph P 2021-2023   Jayne David R.W. 2021-2023   Leversage Jill 2021-2023   MacKay-Dunn R. Hector 2021-2023   MA   Milne George M Jr. 2021-2023   NC   Bailey Jeffrey Allen 2023   NJ   Foster Robert T 2023   Smith Karen L. 2023   IL   Walbert Timothy P 2021-2022   Hayden Michael R 2021				Officer  Since  Most-Recent Title   In   Habig Scott Michael 2022 Chief Commercial Officer 2024   Knappertz Volker 2022 EVP, Research & Development 2024   MD   Donley Matthew Maxwell 2021 EVP, Ops & Strategy 2024   MD   Greenleaf Peter 2021 Chief Executive Officer 2024   MD   Miller Joseph M 2021 Chief Financial Officer 2024   Robertson Stephen P. 2021 EVP, General Counsel 2024   Martin Michael Robert 2021 Chief Business Officer 2023   Colao Massimilano 2021 Chief Commercial Officer 2022   Huizinga Robert Bindert 2021 EVP of Research 2022   Solomons Neil 2021 Chief Medical Officer 2022

        

        

        

        

Securities
Market:  Symbol    Description        (Prices) (Type — Name)   Nasdaq:  AUPH   Common Stock — COM NPV _________  Symbol source:  SEC  As of:  5/2/24		CUSIP, CINS or PPN       Description ← Symbol   Issuer Issue (Class or re: Filing — Name)      To 2024:   05156V 05156V·10·2     Common — COM NPV ← AUPH 05156V·01·1     Options _________  Classes source:  Form 13F Filings that list Section 13(f) Securities